Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Only the revision label was updated, from v3.0.1 to v3.0.2; the rest of the page content appears unchanged.
    Difference
    0.3%
    Check dated 2025-09-12T17:17:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-05T13:54:14.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related details have been removed.
    Difference
    4%
    Check dated 2025-08-29T08:33:32.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-15T00:11:46.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-07T21:59:15.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-07-31T19:32:43.000Z thumbnail image

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.